Johnson & Johnson
Kimberly-Clark to buy Tylenol maker Kenvue for over $40 billion
Kimberly-Clark would be scooping up the former Johnson & Johnson unit after months of struggle.
Eyewear as jewelry and a fragrance campaign inspired by desert blossoms
Exotic recovery experience: New hair care brand comes to Israel
COVID-19 booster shots are crucial, according to a Yale study
US eyes Tuesday deliveries of J&J vaccine, urges minorities to get shots
The officials gave no data on the disparities, but a health policy and research organization, found that POC are getting smaller shares of vaccinations as compared to their share of the population.
US authorizes Johnson & Johnson's COVID-19 vaccine
The US Food and Drug Administration announced the emergency use authorization of the J&J vaccine for adults aged 18 & older following Friday's unanimous endorsement by the agency's panel of experts.
Johnson & Johnson expects COVID-19 vaccine data next week
Public health officials are increasingly counting on single-dose options like the one being tested by J&J to simplify and boost inoculations.
AstraZeneca resumes US COVID-19 vaccine trial as J&J prepares to do same
AstraZeneca paused its US trial on Sept. 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial.
Nine US, European COVID-19 vaccine developers sign pledge to uphold safety
Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines.
COVID-19 vaccine program to start production by late summer - US official
The US government has given grants ranging from several hundred million dollars to over $1 billion to Johnson & Johnson, Moderna Inc, AstraZeneca Plc and Novovax Inc.
COVID-19 supply disruption could be opportunity for Israeli start-ups
Israeli start-ups, focused on going global from day one, have already attracted many large companies to invest and establish a permanent presence in the country.
EU in advanced talks with Johnson & Johnson on COVID-19 vaccine deal
By buying vaccines under development, the EU risks acquiring shots that may eventually prove unsuccessful against COVID-19.
Johnson & Johnson to begin COVID-19 vaccine human trials in July
There are currently no US approved treatments or vaccines for the virus.